Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers
Status:
Completed
Trial end date:
2002-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the ocular tolerance of T1225 1% and 1.5% eye drops versus vehicle after one
instillation twice-daily (morning and evening), in one eye, during 3 days (from Day 0 to Day
2).
To assess azithromycin tear, conjunctiva and plasmatic concentrations, after a 3-day
treatment period